We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ReCor’s Ultrasound System Meets Primary Endpoint in Hypertension Trial
ReCor’s Ultrasound System Meets Primary Endpoint in Hypertension Trial
ReCor Medical announced that its Paradise ultrasound renal denervation system has met its primary efficacy endpoint in a pivotal clinical trial as a treatment for hypertension.